These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38301863)

  • 1. Repetitive head trauma and apoE4 induce chronic cerebrovascular alterations that impair tau elimination from the brain.
    Eisenbaum M; Pearson A; Ortiz C; Koprivica M; Cembran A; Mullan M; Crawford F; Ojo J; Bachmeier C
    Exp Neurol; 2024 Apr; 374():114702. PubMed ID: 38301863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier.
    Eisenbaum M; Pearson A; Gratkowski A; Mouzon B; Mullan M; Crawford F; Ojo J; Bachmeier C
    Fluids Barriers CNS; 2021 Oct; 18(1):48. PubMed ID: 34702292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE Genotype Specific Effects on the Early Neurodegenerative Sequelae Following Chronic Repeated Mild Traumatic Brain Injury.
    Muza P; Bachmeier C; Mouzon B; Algamal M; Rafi NG; Lungmus C; Abdullah L; Evans JE; Ferguson S; Mullan M; Crawford F; Ojo JO
    Neuroscience; 2019 Apr; 404():297-313. PubMed ID: 30711612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma.
    Ojo J; Eisenbaum M; Shackleton B; Lynch C; Joshi U; Saltiel N; Pearson A; Ringland C; Paris D; Mouzon B; Mullan M; Crawford F; Bachmeier C
    Neurobiol Dis; 2021 Mar; 150():105237. PubMed ID: 33383188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE4 expression disrupts tau uptake, trafficking, and clearance in astrocytes.
    Eisenbaum M; Pearson A; Ortiz C; Mullan M; Crawford F; Ojo J; Bachmeier C
    Glia; 2024 Jan; 72(1):184-205. PubMed ID: 37668005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta.
    Ding Y; Palecek SP; Shusta EV
    Fluids Barriers CNS; 2024 Oct; 21(1):79. PubMed ID: 39394110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
    Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
    Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury.
    Main BS; Villapol S; Sloley SS; Barton DJ; Parsadanian M; Agbaegbu C; Stefos K; McCann MS; Washington PM; Rodriguez OC; Burns MP
    Mol Neurodegener; 2018 Apr; 13(1):17. PubMed ID: 29618365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
    Bell RD; Winkler EA; Singh I; Sagare AP; Deane R; Wu Z; Holtzman DM; Betsholtz C; Armulik A; Sallstrom J; Berk BC; Zlokovic BV
    Nature; 2012 May; 485(7399):512-6. PubMed ID: 22622580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
    Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
    Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.
    Nishitsuji K; Hosono T; Nakamura T; Bu G; Michikawa M
    J Biol Chem; 2011 May; 286(20):17536-42. PubMed ID: 21471207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.
    Litvinchuk A; Suh JH; Guo JL; Lin K; Davis SS; Bien-Ly N; Tycksen E; Tabor GT; Remolina Serrano J; Manis M; Bao X; Lee C; Bosch M; Perez EJ; Yuede CM; Cashikar AG; Ulrich JD; Di Paolo G; Holtzman DM
    Neuron; 2024 Feb; 112(3):384-403.e8. PubMed ID: 37995685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of APOE genotype on prion-type propagation of tauopathy.
    Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P
    Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury.
    Cao J; Gaamouch FE; Meabon JS; Meeker KD; Zhu L; Zhong MB; Bendik J; Elder G; Jing P; Xia J; Luo W; Cook DG; Cai D
    Sci Rep; 2017 Sep; 7(1):11372. PubMed ID: 28900205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of pathogenic tau in astrocytes causes a reduction in AQP4 and GLT1, an immunosuppressed phenotype and unique transcriptional responses to repetitive mild TBI without appreciable changes in tauopathy.
    Ortiz C; Pearson A; McCartan R; Roche S; Carothers N; Browning M; Perez S; He B; Ginsberg SD; Mullan M; Mufson EJ; Crawford F; Ojo J
    J Neuroinflammation; 2024 May; 21(1):130. PubMed ID: 38750510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
    Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
    J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.